In cancer, genetic mutations have long been considered to be the only driver of neoplasia (1) . However, there is increasing evidence that epigenetic alterations, defined as changes in the regulation of the expression of gene activity without alteration of genetic structure, could also play a major role in carcinogenesis and cancer (2) . Unlike genetic alterations, for instance, chemicals or drugs could reverse a decrease in gene expression due to epigenetic silencing via aberrant promoter hypermethylation. Therefore, small molecules targeting enzymes responsible for DNA methylation and histone modifications could potentially be important for cancer prevention and therapy.
In this context, inhibitors of DNA methyltransferases (DNMTs) and histone deacetylases (HDACs) have been approved for cancer treatment by the FDA and proven to have therapeutic potency against a number of malignancies (3).
Many classes of dietary phytochemicals have been shown to possess cancer-preventive properties through studies in in vitro and,in vivo animal models and findings from numerous epidemiological studies (4, 5) . Surprisingly, these dietary cancer-preventive agents have also been found to regulate epigenetic activities (6) (7) (8) . For instance, green tea polyphenol (-)-epigallocatechin-3-gallate inhibits DNA methyltransferase and reactivates methylation-silenced genes in cancer cell lines (9) , while sulforaphane and 3, activities, among others (11, 12) . Hence, epigenetic modifications appear to play an important role in cancer prevention in that they can be inhibited by dietary cancer-preventive phytochemicals.
Grape seed extract (GSE) has been extensively investigated for the prevention and treatment of cancers in in vitro and in vivo preclinical models (13) (14) (15) . 
